Literature DB >> 11461907

Interleukin-8 up-regulation by neutrophil elastase is mediated by MyD88/IRAK/TRAF-6 in human bronchial epithelium.

D E Walsh1, C M Greene, T P Carroll, C C Taggart, P M Gallagher, S J O'Neill, N G McElvaney.   

Abstract

Cystic fibrosis is characterized in the lungs by neutrophil-dominated inflammation mediated significantly by neutrophil elastase (NE). Previous work has shown that NE induces interleukin-8 (IL-8) gene expression and protein secretion in bronchial epithelial cells. We sought to determine the intracellular mechanisms by which NE up-regulates IL-8 in bronchial epithelial cells. The data show that stimulation of 16HBE14o(-) cells with NE induced IL-8 protein production and gene expression. Both responses were abrogated by actinomycin D, indicating that regulation is at the transcriptional level. Electrophoretic mobility shift assays demonstrated that nuclear factor kappaB (NFkappaB) was activated in 16HBE14o(-) cells stimulated with NE. Western blot analysis demonstrated that activation of NFkappaB by NE was preceded by phosphorylation and degradation of IkappaB proteins, principally IkappaBbeta. In addition, we observed that interleukin-1 receptor-associated kinase (IRAK) was degraded in 16HBE14o(-) cells stimulated with NE. Quantification of IL-8 reporter gene activity by luminometry demonstrated that dominant negative MyD88 (MyD88Delta) or TRAF-6 (TRAF-6Delta) inhibited IL-8 reporter gene expression in response to NE. Furthermore, MyD88Delta inhibited NE-induced IRAK degradation. These results show that NE induces IL-8 gene up-regulation in bronchial epithelial cells through an IRAK signaling pathway involving both MyD88 and TRAF-6, resulting in degradation of IkappaBbeta and nuclear translocation of NFkappaB. These findings may have implications for therapeutic treatments in the cystic fibrosis condition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461907     DOI: 10.1074/jbc.M103543200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

Review 1.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Role of neutrophils in invasive aspergillosis.

Authors:  Marta Feldmesser
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

Review 3.  Neutrophil serine proteases fine-tune the inflammatory response.

Authors:  Christine T N Pham
Journal:  Int J Biochem Cell Biol       Date:  2007-11-29       Impact factor: 5.085

4.  Neutrophil elastase contributes to the pathological vascular permeability characteristic of diabetic retinopathy.

Authors:  Haitao Liu; Emma M Lessieur; Aicha Saadane; Sarah I Lindstrom; Patricia R Taylor; Timothy S Kern
Journal:  Diabetologia       Date:  2019-10-14       Impact factor: 10.122

5.  The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.

Authors:  Leandra Figueroa; Yanbao Xiong; Chang Song; Wenji Piao; Stefanie N Vogel; Andrei E Medvedev
Journal:  J Immunol       Date:  2012-04-02       Impact factor: 5.422

6.  Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare Diseases.

Authors:  Adam Wanner; Stephen C Groft; J Russell Teagarden; Jeffrey Krischer; Barry R Davis; Christopher S Coffey; David H Hickam; Jeffrey Teckman; David R Nelson; Michael L McCaleb; Rohit Loomba; Charlie Strange; Robert A Sandhaus; Mark Brantly; Jonathan M Edelman; Albert Farrugia
Journal:  Chronic Obstr Pulm Dis       Date:  2015-04-28

7.  2-O, 3-O-desulfated heparin inhibits neutrophil elastase-induced HMGB-1 secretion and airway inflammation.

Authors:  Kathryn L Griffin; Bernard M Fischer; Apparao B Kummarapurugu; Shuo Zheng; Thomas P Kennedy; Narayanam V Rao; W Michael Foster; Judith A Voynow
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

8.  Reactive oxygen species regulate neutrophil recruitment and survival in pneumococcal pneumonia.

Authors:  Helen M Marriott; Laura E Jackson; Thomas S Wilkinson; A John Simpson; Tim J Mitchell; David J Buttle; Simon S Cross; Paul G Ince; Paul G Hellewell; Moira K B Whyte; David H Dockrell
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

9.  Antiproteases as therapeutics to target inflammation in cystic fibrosis.

Authors:  Derek J Quinn; Sinéad Weldon; Clifford C Taggart
Journal:  Open Respir Med J       Date:  2010-03-30

10.  Potent elastase inhibitors from cyanobacteria: structural basis and mechanisms mediating cytoprotective and anti-inflammatory effects in bronchial epithelial cells.

Authors:  Lilibeth A Salvador; Kanchan Taori; Jason S Biggs; Jean Jakoncic; David A Ostrov; Valerie J Paul; Hendrik Luesch
Journal:  J Med Chem       Date:  2013-01-28       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.